Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Leap Therapeutics, Inc. (Nasdaq:LPTX) to Present Corporate Overview at 42nd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 3, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 42^nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Leap Presentation Details:

42^nd Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 10, 2024
Time: 1:30 p.m. Pacific Time

A live webcast of the presentation may be accessed on the Investors page of the company's website at https://investors.leaptx.com/, where a replay of the events will also be available for a limited time.

About Leap Therapeutics

Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. FL-301, is a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. Leap also has preclinical antibody programs targeting Claudin18.2/CD137 and GDF15. For more information about Leap Therapeutics, visit http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via https://investors.leaptx.com/.

CONTACT:

Douglas E. Onsi
President & Chief Executive Officer
Leap Therapeutics, Inc.
617-714-0360
donsi@leaptx.com

Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-therapeutics-to-participate-at-the-42nd-annual-jp-morgan-healthcare-conference-302024033.html

SOURCE Leap Therapeutics, Inc.

FAQ

When and where is Leap Therapeutics, Inc. presenting at the 42nd Annual J.P. Morgan Healthcare Conference?

Leap Therapeutics, Inc. will present a corporate overview on Wednesday, January 10, 2024, at 1:30 p.m. Pacific Time in San Francisco, CA.

Where can the live webcast of the presentation be accessed?

The live webcast of the presentation can be accessed on the Investors page of the company's website at https://investors.leaptx.com/.

Will there be a replay of the events available?

Yes, a replay of the events will also be available for a limited time on the Investors page of the company's website at https://investors.leaptx.com/.